Jane Street Group, LLC Aurinia Pharmaceuticals Inc. Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 464,001 shares of AUPH stock, worth $3.84 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

464,001

Previous 247,228 87.68%

Holding current value

$3.84 Million

Previous $1.41 Million 141.03%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$5.32 - $7.33 $1.15 Million - $1.59 Million	216,773 Added 87.68%	464,001 $3.4 Million
Q2 2024 Aug 14, 2024	BUY	$4.81 - $5.78 $660,951 - $794,241	137,412 Added 125.13%	247,228 $1.41 Million
Q1 2024 May 15, 2024	SELL	$4.93 - $9.31 $2.33 Million - $4.4 Million	-472,671 Reduced 81.15%	109,816 $550,000
Q4 2023 Feb 14, 2024	BUY	$7.13 - $9.49 $2.02 Million - $2.69 Million	283,030 Added 94.51%	582,487 $5.24 Million
Q3 2023 Nov 14, 2023	SELL	$7.77 - $12.27 $546,246 - $862,605	-70,302 Reduced 19.01%	299,457 $2.33 Million
Q2 2023 Aug 14, 2023	BUY	$8.96 - $11.69 $29,863 - $38,962	3,333 Added 0.91%	369,759 $3.58 Million
Q1 2023 May 15, 2023	BUY	$5.94 - $11.27 $1.38 Million - $2.62 Million	232,868 Added 174.36%	366,426 $4.02 Million
Q4 2022 Feb 14, 2023	SELL	$4.11 - $8.14 $1.12 Million - $2.22 Million	-272,433 Reduced 67.1%	133,558 $576,000
Q3 2022 Nov 14, 2022	SELL	$6.66 - $12.39 $1.22 Million - $2.27 Million	-183,105 Reduced 31.08%	405,991 $3.05 Million
Q2 2022 Aug 16, 2022	BUY	$8.95 - $12.8 $2.24 Million - $3.2 Million	250,115 Added 73.78%	589,096 $5.92 Million
Q1 2022 May 17, 2022	SELL	$10.05 - $22.48 $1.5 Million - $3.35 Million	-148,886 Reduced 30.52%	338,981 $4.2 Million
Q4 2021 Feb 15, 2022	BUY	$17.78 - $33.08 $2.43 Million - $4.51 Million	136,431 Added 38.82%	487,867 $11.2 Million
Q3 2021 Nov 16, 2021	BUY	$10.93 - $23.55 $781,123 - $1.68 Million	71,466 Added 25.53%	351,436 $5.76 Million
Q2 2021 Aug 16, 2021	BUY	$10.0 - $14.52 $2.5 Million - $3.63 Million	249,859 Added 829.79%	279,970 $3.63 Million
Q1 2021 May 18, 2021	SELL	$12.3 - $18.73 $2.72 Million - $4.14 Million	-220,972 Reduced 88.01%	30,111 $391,000
Q4 2020 Feb 17, 2021	BUY	$12.94 - $16.05 $1.33 Million - $1.65 Million	103,090 Added 69.66%	251,083 $3.47 Million
Q3 2020 Nov 17, 2020	BUY	$13.19 - $16.66 $538,376 - $680,011	40,817 Added 38.08%	147,993 $2.18 Million
Q2 2020 Aug 17, 2020	BUY	$14.12 - $18.33 $1.15 Million - $1.49 Million	81,152 Added 311.84%	107,176 $1.74 Million
Q4 2019 Feb 14, 2020	BUY	$3.88 - $21.42 $100,973 - $557,434	26,024 New	26,024 $527,000
Q4 2018 Feb 15, 2019	SELL	$5.08 - $6.83 $138,978 - $186,855	-27,358 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$5.27 - $6.64 $144,176 - $181,657	27,358 New	27,358 $182,000
Q4 2017 Feb 15, 2018	SELL	$4.53 - $7.09 $45,485 - $71,190	-10,041 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$5.71 - $6.9 $57,334 - $69,282	10,041	10,041 $63,000

Others Institutions Holding AUPH

# of Institutions

211

Shares Held

58.4M

Call Options Held

1.14M

Put Options Held

1.51M

View Full List

About Aurinia Pharmaceuticals Inc.

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.17B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

More about AUPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Aurinia Pharmaceuticals Inc. Transaction History